Ursodiol and Yasmin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ursodiol (ursodiol) and Yasmin (drospirenone; ethinyl estradiol). Common drug interactions include injury among females.

The phase IV clinical study analyzes what interactions people have when they take Ursodiol and Yasmin. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Ursodiol?

Ursodiol has active ingredients of ursodiol. It is often used in primary biliary cirrhosis. eHealthMe is studying from 19,061 Ursodiol users. Check the latest studies of Ursodiol.

What is Yasmin?

Yasmin has active ingredients of drospirenone; ethinyl estradiol. It is often used in birth control. eHealthMe is studying from 48,855 Yasmin users. Check the latest studies of Yasmin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

12 people who take Ursodiol and Yasmin together, and have interactions are studied.

Ursodiol and Yasmin drug interactions.

What are the common drug interactions of Ursodiol and Yasmin, by gender? *:

female:

  1. Injury
  2. Cholecystitis chronic (long lasting infection of gallbladder)
  3. Thrombophlebitis superficial (swelling (inflammation) of a superficial vein caused by a blood clot)
  4. Abdominal pain upper
  5. Abdominal distension
  6. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  7. Cholecystitis acute (rapid infection of gallbladder)
  8. Depression
  9. Eating disorder
  10. Flatulence (flatus expelled through the anus)

male:

n/a

What are the common drug interactions of Ursodiol and Yasmin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Abdominal pain upper
  2. Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
  3. Chest pain
  4. Cholecystitis chronic (long lasting infection of gallbladder)
  5. Dyspepsia (indigestion)
  6. Gallbladder disorder
  7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. Nausea (feeling of having an urge to vomit)
  9. Pain
  10. Procedural pain

20-29:

  1. Cholecystitis (infection of gallbladder)
  2. Injury
  3. Pain
  4. Pulmonary embolism (blockage of the main artery of the lung)
  5. Vena cava thrombosis (clotting of the blood in large vein carrying deoxygenated blood into the heart)

30-39:

  1. Injury
  2. Cholecystitis chronic (long lasting infection of gallbladder)
  3. Abdominal tenderness
  4. Biliary colic
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Depression
  8. Eating disorder
  9. Emotional distress
  10. Gastric disorder (disease of stomach)

40-49:

  1. Abdominal distension
  2. Anxiety
  3. Biliary colic
  4. Cholecystitis acute (rapid infection of gallbladder)
  5. Diarrhoea
  6. Dyspepsia (indigestion)
  7. Emotional distress
  8. Flatulence (flatus expelled through the anus)
  9. Injury
  10. Nausea (feeling of having an urge to vomit)

50-59:

  1. Gallbladder disorder
  2. Renal failure (kidney dysfunction)
  3. Emotional distress

60+:

  1. Abdominal pain upper
  2. Cholecystitis chronic (long lasting infection of gallbladder)
  3. Diarrhoea
  4. Electrocardiogram qt prolonged
  5. Injury
  6. Multi-organ failure (multisystem organ failure)
  7. Nausea (feeling of having an urge to vomit)
  8. Pain
  9. Sepsis (a severe blood infection that can lead to organ failure and death)

What are the existing conditions these people have? *

  1. Migraine (headache): 4 people, 33.33%
  2. Pain: 3 people, 25.00%
  3. Premenstrual Syndrome: 2 people, 16.67%
  4. Multiple Allergies (allergy to multiple agents): 2 people, 16.67%
  5. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 16.67%
  6. Liver Disorder (liver diseases): 2 people, 16.67%
  7. Muscle Spasms (muscle contraction): 1 person, 8.33%
  8. Painful Menstrual Periods: 1 person, 8.33%
  9. Menstruation Irregular: 1 person, 8.33%
  10. Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Ursodiol and Yasmin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ursodiol and Yasmin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ursodiol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Yasmin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ursodiol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Yasmin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ursodiol and drospirenone; ethinyl estradiol (the active ingredients of Ursodiol and Yasmin, respectively), and Ursodiol and Yasmin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: